Biography
John is regularly recognized among the country’s leading securities and business litigators. In 2017, he was selected by the National Law Journal as one of 25 “Litigation Trailblazers” nationwide, and is currently recognized as one of the top 15 leading lawyers for Securities Litigation in New York by Chambers USA, which refers to him as an “excellent securities litigator with deep experience in the subject matter” with “a pragmatic and efficient approach” who can advise “not only on strictly legal issues but also highly strategic matters.” John also is currently recognized by Legal 500 as a top-ranked “Hall of Fame” lawyer nationwide for both Securities Litigation: Defense and M&A Litigation: Defense, where clients describe him as “brilliant, the best in the business; tough yet smart,” “as good as they come,” and “a national leader in this space,” and note that he “is at the top of the list for securities cases no matter how big or complicated” and “sees the big picture and manages his team efficiently through the granular issues.” He also has been recognized as one of America’s leading securities litigators by Benchmark Litigation and Best Lawyers in America, and as a New York “Super Lawyer.” Additionally, since 2016, John has been recognized as a “Life Sciences Star” by LMG Life Sciences Guide.
John has litigated many seminal securities, M&A, fiduciary duty, and other corporate disputes that have resulted in judicial decisions that have set or overturned precedent, and has secured his clients complete trial and appellate victories in cases collectively implicating billions of dollars.